Apotea AB (publ) (STO:APOTEA)
67.05
+1.65 (2.52%)
At close: Apr 28, 2026
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 6.98 billion as of April 29, 2026. Its market cap has decreased by -7.26% in one year.
Market Cap
6.98B
Enterprise Value
7.29B
Revenue
7.21B
Ranking
n/a
PE Ratio
30.51
Stock Price
67.05
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 6.98B, a decrease of -19.15%. That is a compound annual growth rate of -14.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 6.98B | -27.29% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 137.78B |
| Getinge AB | 52.95B |
| Sectra AB | 50.75B |
| Camurus AB | 32.12B |
| Ambea AB | 11.31B |
| Dynavox Group AB | 9.20B |
| Xvivo Perfusion AB | 8.73B |
| Synsam AB | 8.22B |